Open | $5.520 |
Close | $5.910 |
Volume / Avg. | 2.003M / 1.471M |
Day Range | 5.480 - 5.910 |
52 Wk Range | 1.240 - 6.300 |
Market Cap | $1.759B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 60 |
Short Interest | 0.76% |
Days to Cover | 1.83 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Amneal Pharmaceuticals (NASDAQ: AMRX) through any online brokerage.
Other companies in Amneal Pharmaceuticals’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), CymaBay Therapeutics (NASDAQ:CBAY), Tarsus Pharmaceuticals (NASDAQ:TARS) and Neumora Therapeutics (NASDAQ:NMRA).
The latest price target for Amneal Pharmaceuticals (NASDAQ: AMRX) was reported by Goldman Sachs on Monday, March 4, 2024. The analyst firm set a price target for 6.25 expecting AMRX to rise to within 12 months (a possible 9.08% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Amneal Pharmaceuticals (NASDAQ: AMRX) is $5.73 last updated March 18, 2024 at 6:17 PM EDT.
There are no upcoming dividends for Amneal Pharmaceuticals.
Amneal Pharmaceuticals’s Q1 earnings are confirmed for Friday, May 3, 2024.
There is no upcoming split for Amneal Pharmaceuticals.
Amneal Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.